S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
AIMD · Ainos, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$0.89
-0.01
(-1.28%)
● At close: October 21 at 4:00:00 PM EDT
$1.00
+0.12
(+13.62%)
Overnight:
11:46:44 PM EDT
DAY'S RANGE
$0.89
$0.89
$0.89
52-WEEK RANGE
$0.89
$0.80
$4.03
What's happening
- AIMD is down 1.28% today, trading at $0.89. — Live quote
- It's trading within 3% of its 52-week low ($0.80). (Finnhub fundamentals)
- Volume today (504) is well below its 3-month average of 150,300. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
AIMD
-43.20%
vs S&P 500
-55.60%
1-YEAR RETURN
AIMD
-76.54%
vs S&P 500
-91.90%
6-MONTH RETURN
AIMD
-42.14%
3-MONTH RETURN
AIMD
-41.42%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2025-04-26 (Q1 2025)
$-0.21
Est. $—
2024-04-26 (Q1 2024)
$-0.57
Est. $—
2007-04-26 (Q1 2007)
$-14.25
Est. $-19.38
BEAT +26.5%
2007-01-26 (Q4 2006)
$-4.75
Est. $-14.54
BEAT +67.3%
Valuation Measures & Ratios
Enterprise Value4$19.0M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)488.81
Price / Book75.04
EV4 / Revenue1399.85
EV4 / EBITDA6.37
Profit Margin-106283.31%
Operating Margin-101210.22%
Return on Equity (ROE8)-217.50%
Return on Assets (ROA9)-67.87%
Avg Volume (3M)150,300
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $14.3M | $8.2M | $16.0M | $10.7M | $7.9M |
| P/E | -1.02 | -0.64 | -1.14 | -0.75 | -0.59 |
| Price/Sales | 2002.37 | 72.08 | — | — | — |
| Price/Book | 4.36 | 1.43 | 1.59 | 0.93 | 0.60 |
| EV/Revenue | 1803.17 | 46.98 | — | — | — |
| ROE | -428.48% | -224.22% | -139.39% | -124.67% | -102.85% |
| ROA | -71.93% | -57.80% | -61.74% | -59.63% | -51.21% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short41,264
Change from Prior Settlement-26.03%
% of Float—
Days to Cover (Short Ratio)1.00
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-10-16; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -96.8% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -106283.3%. Finnhub fundamentals ↗
- Trailing 52-week price return is -76.5%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on AIMD
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $152 | $161 | $2.2K | $4.7K | $106.2K | — | — | $20.7K |
| Gross profit | $99 | -$602 | $1.7K | $3.7K | $88.0K | -$547 | -$25.4K | -$6.0K |
| Operating income | -$4.4M | -$2.3M | -$2.8M | -$3.7M | -$3.2M | -$3.0M | -$3.0M | -$3.1M |
| Net income | -$4.6M | -$2.5M | -$2.9M | -$4.1M | -$3.3M | -$3.7M | -$3.2M | -$3.3M |
| EPS (diluted) | $-0.62 | $-0.41 | $-0.64 | $-0.99 | $-1.04 | $-1.64 | $-2.45 | $-0.57 |
| EPS (basic) | $-0.62 | $-0.41 | $-0.64 | $-0.99 | $-1.04 | $-1.64 | $-2.45 | $-0.57 |
| Operating margin | -$2.9M | -$1.4M | -$128.5K | -$80.3K | -$3.0K | — | — | -$15.1K |
| Net margin | -$3.0M | -$1.5M | -$135.3K | -$87.6K | -$3.1K | — | — | -$16.0K |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $19.6M | $22.1M | $20.9M | $22.7M | $23.9M | $26.4M | $28.8M | $31.4M |
| Total liabilities | $16.3M | $16.4M | $13.3M | $12.6M | $12.5M | $13.2M | $13.3M | $13.3M |
| Stockholders' equity | $3.3M | $5.7M | $7.6M | $10.0M | $11.4M | $13.1M | $15.5M | $18.0M |
| Total current assets | $2.2M | $3.5M | $1.1M | $1.7M | $1.7M | $3.1M | $4.3M | $5.6M |
| Total current liabilities | $16.3M | $6.3M | $1.1M | $581.4K | $602.8K | $1.5M | $4.0M | $4.1M |
| Cash & equivalents | $1.4M | $2.8M | $417.4K | $1.1M | $1.2M | $2.6M | $3.9M | $5.2M |
| Accounts receivable | — | $23 | $22 | $62 | $187 | $91 | $56 | — |
| Inventory | $308.7K | $315.6K | $295.6K | $166.9K | $160.1K | $141.8K | $143.8K | $160.7K |
| Other current assets | $456.9K | $362.5K | $425.9K | $425.8K | $350.5K | $280.8K | $301.1K | $331.9K |
| Property, plant & equipment | $239.6K | $290.1K | $343.3K | $414.6K | $495.1K | $494.4K | $559.6K | $649.1K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible assets | $17.0M | $18.1M | $19.2M | $20.4M | $21.5M | $22.6M | $23.7M | $24.9M |
| Other non-current assets | $150.0K | $161.1K | $163.0K | $178.0K | $187.3K | $174.5K | $174.4K | $183.2K |
| Accounts payable | — | — | — | — | — | — | — | — |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Deferred revenue (current) | $350.0K | $350.0K | $350.0K | — | — | — | $106.3K | $110.1K |
| Other non-current liabilities | — | $1.0M | $1.2M | $1.1M | $876.6K | $708.0K | $348.9K | $216.8K |
| Common stock & paid-in capital | $85.4K | $72.7K | $69.8K | $47.9K | $42.7K | $172.2K | $30.9K | $138.1K |
| Retained earnings | -$74.6M | -$70.0M | -$67.5M | -$63.1M | -$60.1M | -$56.0M | -$52.7M | -$48.1M |
| Accumulated other comprehensive income (loss) | -$237.6K | -$261.7K | -$249.3K | -$214.5K | -$148.1K | -$450.2K | -$409.5K | -$244.4K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.4M | -$983.4K | -$855.0K | -$1.2M | -$1.4M | -$1.2M | -$864.2K | -$1.5M |
| Investing cash flow | $7.4K | -$79 | $10.9K | $4.9K | $2.5K | -$20.6K | $13.3K | -$18.8K |
| Financing cash flow | $0 | $3.4M | $155.8K | $1.1M | -$295.5K | $14.6K | -$270.0K | -$1.5M |
| Free cash flow | -$1.5M | -$992.0K | -$853.5K | -$1.2M | -$1.3M | -$1.3M | -$865.1K | -$1.5M |
| Capital expenditures | $5.8K | $8.5K | -$1.5K | $10.1K | -$7.7K | $33.6K | $908 | $10.1K |
| Share-based compensation | $2.0M | — | $0 | $348.4K | $1.3M | $55.2K | $2.2M | $470.8K |
| Deferred income taxes | — | — | — | — | — | — | — | — |
| Change in accounts receivable | -$23 | $1 | -$40 | -$125 | $96 | $35 | $56 | -$9 |
| Change in inventory | -$4.1K | $27.5K | $128.7K | $6.8K | $18.2K | -$1.9K | -$16.9K | -$5.6K |
| Change in accounts payable | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $124.2K | $20.7K | $122.1K | $3.5M | $594.6K |
| Gross profit | $102.9K | -$31.9K | -$253.7K | $1.4M | $410.4K |
| Operating income | -$14.0M | -$13.8M | -$13.2M | -$14.0M | -$3.9M |
| Net income | -$14.8M | -$14.9M | -$13.8M | -$14.0M | -$3.9M |
| EPS (diluted) | $-3.46 | $-7.82 | $-3.36 | — | — |
| EPS (basic) | $-3.46 | $-7.82 | $-3.36 | — | — |
| Operating margin | -$11.3K | -$66.8K | -$10.8K | -$397 | -$650 |
| Net margin | -$11.9K | -$71.7K | -$11.3K | -$398 | -$654 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $20.9M | $28.8M | $31.8M | $37.1M | $40.8M |
| Total liabilities | $13.3M | $13.3M | $7.4M | $2.5M | $30.6M |
| Stockholders' equity | $7.6M | $15.5M | $24.4M | $34.6M | $10.2M |
| Total current assets | $1.1M | $4.3M | $2.5M | $2.8M | $2.2M |
| Total current liabilities | $1.1M | $4.0M | $1.3M | $2.5M | $30.6M |
| Cash & equivalents | $417.4K | $3.9M | $1.9M | $1.9M | $1.8M |
| Accounts receivable | $22 | $56 | $455 | $201.5K | $0 |
| Inventory | $295.6K | $143.8K | $167.6K | $595.2K | $0 |
| Other current assets | $425.9K | $301.1K | $419.5K | $195.8K | $466.2K |
| Property, plant & equipment | $343.3K | $559.6K | $876.6K | $1.4M | $1.2M |
| Intangible assets | $19.2M | $23.7M | $28.3M | $32.8M | $37.3M |
| Other non-current assets | $163.0K | $174.4K | $208.8K | $80.7K | $466.2K |
| Deferred revenue (current) | $350.0K | $106.3K | $112.6K | — | — |
| Other non-current liabilities | $1.2M | $348.9K | $135.8K | $8.1K | — |
| Common stock & paid-in capital | $69.8K | $30.9K | $46.8K | $40.0K | $96.3K |
| Retained earnings | -$67.5M | -$52.7M | -$37.9M | -$24.1M | -$10.1M |
| Accumulated other comprehensive income (loss) | -$249.3K | -$409.5K | -$270.5K | -$201.7K | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$4.6M | -$5.8M | -$4.7M | -$3.0M | -$1.2M |
| Investing cash flow | -$2.2K | -$125.3K | -$101.5K | -$630.2K | -$180.5K |
| Financing cash flow | $1.0M | $8.0M | $4.9M | $3.9M | $3.2M |
| Free cash flow | -$4.6M | -$5.8M | -$4.8M | -$3.7M | -$1.4M |
| Capital expenditures | $34.6K | $21.3K | $93.0K | $633.8K | $143.8K |
| Share-based compensation | $1.7M | $3.5M | $1.1M | $6.4M | -$10.7K |
| Deferred income taxes | — | — | — | $2.8M | — |
| Change in accounts receivable | -$34 | -$399 | -$201.1K | $201.5K | $0 |
| Change in inventory | $151.8K | -$23.8K | -$221.8K | $595.2K | -$3.0K |
| Change in accounts payable | — | — | — | — | $65.2K |
| Share repurchases | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding AIMD as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-11-25 to 2026-06-05
Recent transactions
- Insiders have net sold 187,211 shares over the last 182 days, across 9 purchases and 6 sales.
- Most recent: chiang yao-chung (Director) — Open market purchase of 3,500 shares on 2026-06-05.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)10,879 sh(9 txns)
Sales (open market)198,090 sh(6 txns)
Net Shares-187,211
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| chiang yao-chung | Director | Open market purchase | 2026-06-05 | 3,500 |
| lee ting-chuan | Director | Open market sale | 2026-05-26 | 109,988 |
| Taiwan Carbon Nano Technology Corp | 10% owner | Open market sale | 2026-05-26 | 41,000 |
| TSAI CHUN-JUNG | Director | Open market sale | 2026-05-26 | 27,718 |
| tsai chun-hsien | CEO, PRESIDENT, CHAIRMAN | Grant / award | 2026-04-15 | 300,000 |
| chang wen-han | Director | Grant / award | 2025-11-25 | 50,000 |
| tsai chung-yi | Director | Grant / award | 2025-11-25 | 50,000 |
| WEI PAO-SHENG | Director | Grant / award | 2025-11-25 | 50,000 |
| Lee Hsin-Liang Christopher | CFO | Grant / award | 2025-11-25 | 20,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-06-05 | chiang yao-chung | Director | Open market purchase | 3,500 | $2.05 |
| 2026-06-03 | chiang yao-chung | Director | Open market purchase | 2,000 | $2.13 |
| 2026-05-28 | chiang yao-chung | Director | Open market purchase | 250 | $2.30 |
| 2026-05-27 | chiang yao-chung | Director | Open market purchase | 2,000 | $2.00 |
| 2026-05-26 | lee ting-chuan | Director | Open market sale | 109,988 | $1.90 |
| 2026-05-26 | Taiwan Carbon Nano Technology Corp | 10% owner | Open market sale | 41,000 | $2.36 |
| 2026-05-26 | TSAI CHUN-JUNG | Director | Open market sale | 27,718 | $1.87 |
| 2026-05-22 | TSAI CHUN-JUNG | Director | Open market sale | 1,082 | $1.55 |
| 2026-05-22 | lee ting-chuan | Director | Open market sale | 9,302 | $1.57 |
| 2026-05-21 | lee ting-chuan | Director | Open market sale | 9,000 | $1.56 |
| 2026-05-19 | chiang yao-chung | Director | Open market purchase | 2,200 | $1.68 |
| 2026-05-18 | chiang yao-chung | Director | Open market purchase | 500 | $1.65 |
| 2026-05-05 | chiang yao-chung | Director | Open market purchase | 129 | $1.70 |
| 2026-04-30 | chiang yao-chung | Director | Open market purchase | 200 | $1.68 |
| 2026-04-29 | chiang yao-chung | Director | Open market purchase | 100 | $1.75 |
| 2026-04-15 | TSAI CHUN-JUNG | Director | Grant / award | 330,000 | $1.61 |
| 2026-04-15 | tsai chun-hsien | CEO, PRESIDENT, CHAIRMAN | Grant / award | 300,000 | $1.61 |
| 2026-04-15 | lee ting-chuan | Director | Grant / award | 570,000 | $1.61 |
| 2026-01-28 | Taiwan Carbon Nano Technology Corp | 10% owner | Open market sale | 46,000 | $2.17 |
| 2026-01-09 | Taiwan Carbon Nano Technology Corp | 10% owner | Open market sale | 431 | $1.86 |
| 2026-01-08 | Taiwan Carbon Nano Technology Corp | 10% owner | Open market sale | 850 | $1.80 |
| 2025-11-25 | chiang yao-chung | Director | Grant / award | 50,000 | $2.10 |
| 2025-11-25 | tsai chun-hsien | CEO, PRESIDENT, CHAIRMAN | Grant / award | 80,000 | $2.10 |
| 2025-11-25 | lee ting-chuan | Director | Grant / award | 80,000 | $2.10 |
| 2025-11-25 | chang wen-han | Director | Grant / award | 50,000 | $2.10 |
| 2025-11-25 | tsai chung-yi | Director | Grant / award | 50,000 | $2.10 |
| 2025-11-25 | WEI PAO-SHENG | Director | Grant / award | 50,000 | $2.10 |
| 2025-11-25 | Lee Hsin-Liang Christopher | CFO | Grant / award | 20,000 | $2.10 |
| 2025-11-25 | TSAI CHUN-JUNG | Director | Grant / award | 80,000 | $2.10 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 06:30 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-16 | 8-K | 2026-10-14 | View on SEC.gov → |
| 2026-09-28 | 8-K | 2026-09-24 | View on SEC.gov → |
| 2026-08-03 | 8-K | 2026-08-03 | View on SEC.gov → |
| 2026-08-03 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-10 | 8-K | 2026-07-09 | View on SEC.gov → |
| 2026-07-09 | 8-K | 2026-07-03 | View on SEC.gov → |
| 2026-06-09 | 4 | 2026-06-05 | View on SEC.gov → |
| 2026-06-05 | 4 | 2026-06-03 | View on SEC.gov → |
| 2026-06-01 | 4 | 2026-05-28 | View on SEC.gov → |
| 2026-05-29 | 4 | 2026-05-27 | View on SEC.gov → |
| 2026-05-27 | 4 | 2026-05-26 | View on SEC.gov → |
| 2026-05-27 | 4 | 2026-05-26 | View on SEC.gov → |
Recent news
Headlines about AIMD (Ainos, Inc.). Links open the publisher — we don’t host full articles.
-
Ainos Inc. (AIMD) Slips 3.27% to $0.90 as Shares Test Lower Support Zone - Hedge Fund Exposure
www.dars.gov.et · 2026-10-20 -
AIMD 8-K & SEC Filings
Yahoo Finance · 2026-10-16 -
Ainos' Stock Sinks To US$0.96, But Insiders Sold Even Lower
Simply Wall Street · 2026-10-15 -
Ainos Completes VELDONA Technology Transfer, Triggering $600,000 License Payment
Yahoo Finance · 2026-09-30 -
Ainos Completes Delivery of 1,400 AI Nose Systems to ASE Under $2.1 Million, Three-Year Contract
Yahoo Finance · 2026-09-29 -
Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence
Yahoo Finance · 2026-09-28 -
Ainos signs VELDONA license framework with BioPhoenix, outlining up to $10M in conditional consideration
Seeking Alpha · 2026-09-24 -
Ainos and BioPhoenix Sign VELDONA License Agreement, Establishing a Potential $10 Million Collaboration Framework
Yahoo Finance · 2026-09-24
No headlines in this category right now — try “All”.